FDA Adverse Event Injury Summary report: N

ETHIBOND EXTRA & EXCEL POLYESTER SUTURE UNKNOWN

MDR report key: 7760137 · Received August 7, 2018

Report

Report Number
2210968-2018-74991
Event Type
Injury
Date Received
August 7, 2018
Report Date
July 31, 2018
Manufacturer
ETHICON INC.
Product Code
GAT
PMA / PMN Number
K946173
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CITATION: FEMALE PELVIC MEDICINE & RECONSTRUCTIVE SURGERY & VOLUME 17, NUMBER 5, SUPPLEMENT 2, SEPTEMBER/OCTOBER 2011. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED VIA JOURNAL ARTICLE: "TITLE : RISK FACTORS FOR VAGINAL MESH EXPOSURE AFTER ROBOTIC-ASSISTED LAPAROSCOPIC SACROCOLPOPEXY: A RETROSPECTIVE COHORT STUDY" AUTHOR: D. EL-KHAWAND, S. A. WEHBE, D. ARUNACHALAM, E. SAKS, H. GOLDSTEIN, K. WHITMORE, B. VAKILI CITATION: FEMALE PELVIC MEDICINE & RECONSTRUCTIVE SURGERY & VOLUME 17, NUMBER 5, SUPPLEMENT 2, SEPTEMBER/OCTOBER 2011 THE PURPOSE OF THIS RETROSPECTIVE COHORT STUDY WAS TO IDENTIFY RISK FACTORS FOR VAGINAL MESH EXPOSURE AFTER ROBOTIC-ASSISTED LAPAROSCOPIC SACROCOLPOPEXY (RSC). BETWEEN JAN2009 AND DEC2010, 93 FEMALE PATIENTS UNDERWENT RSC. IN THE PROCEDURE, ETHIBOND OR PROLENE SUTURES WERE USED TO FIX THE MESH. IN THE MEAN FOLLOW-UP OF 20 WEEKS (SD±15 WEEKS), EXPOSURE WAS NOTED IN 16 PATIENTS COMPRISING OF MESH EXPOSURE (N=15) AND SUTURE EXPOSURE (N=1). TWELVE OF THESE EXPOSURES UNDERWENT SURGICAL THERAPY AFTER FAILED MEDICAL TREATMENT. IN THESE CASES, 30% UTILIZED ETHIBOND SUTURES AND 9.8% UTILIZED PROLENE SUTURES. ALTHOUGH NO DEFINITIVE RISK FACTORS WERE IDENTIFIED ON MULTIVARIATE ANALYSIS, INCIDENTAL ANTERIOR VAGINOTOMY, EARLY LEARNING CURVE, CAUTERY USE, AND SUTURE MATERIAL MAY BE ASSOCIATED WITH HIGHER VAGINAL MESH EXPOSURE RATES AFTER RSC.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
598048 ETHIBOND EXTRA & EXCEL POLYESTER SUTURE UNKNOWN SUTURE, NONABSORBABLE, SYNTHETIC GAT ETHICON INC. UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention